BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioNJ
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230913T083000
DTEND;TZID=America/New_York:20230913T153000
DTSTAMP:20260504T221312
CREATED:20230309T001446Z
LAST-MODIFIED:20230912T095135Z
UID:7057-1694593800-1694619000@bionj.org
SUMMARY:2023 BioNJ Manufacturing Briefing
DESCRIPTION:Registration is now closed. Please email MCarapucci@BioNJ.org to be added to our waiting list. \n\n\n\n\n\n\n\nRising to the Challenge: Manufacturing & Supplying Therapies in Today’s Reality\n\n\n\nWednesday\, September 13\, 2023 • 8:30 a.m.-3:30 p.m.\n\n\n\nRutgers University\, Busch Campus Student Center • 604 Bartholomew Road\, Piscataway\, NJ 08854 \n\n\n\n\nBecome a Sponsor\n\n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry\, such as Controlling the Cost of Goods; Digital\, Automation and AI in Biotech Manufacturing; and Strategic Partnerships with CMOs and CDMOs. Plus\, be on hand for… \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nStay after the program to tour Rutgers Pharma Manufacturing Facility ─ The two-story\, state-of-the-art continuous manufacturing lab is a $2 million dollar facility built with funding from the National Science Foundation that is providing biopharmaceutical manufacturers with an alternative to traditional batch processing\, including efficiencies that improve quality\, consistency\, production speed and cost. (Tour is on a first-come\, first-serve basis and number of participants is limited.) \n\n\n\nBe sure to forward this email to colleagues and customers who could also benefit from these topical discussions and perspectives! Registration is $95 for BioNJ Members and $175 for Future Members. Click here to register.
URL:https://bionj.org/event/bionj-manufacturing-briefing/
LOCATION:Rutgers University\, Busch Campus Student Center\, 604 Bartholomew Road\, Piscataway\, New Jersey\, 08854\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/03/Manufacturing-Briefing-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230921T123000
DTEND;TZID=America/New_York:20230921T133000
DTSTAMP:20260504T221312
CREATED:20230804T105609Z
LAST-MODIFIED:20230924T130445Z
UID:8037-1695299400-1695303000@bionj.org
SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar
DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration\n\n\n\nThursday\, September 21\, 2023 • 12:30 p.m.-1:30 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the highly anticipated next phase of our work in a series of programs where life sciences professionals can share their health equity in clinical trials initiatives\, ask questions and explore possible collaboration opportunities. \n\n\n\nOn the heels of our recently debuted Best Practices Database featuring a diverse array of initiatives being offered by the community\, please join us virtually on Thursday\, September 21\, from 12:30 p.m. to 1:30 p.m.\, for BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration. Click here to register for FREE. \n\n\n\nLearn about three innovative initiatives which have the potential to be game changers: \n\n\n\n\n\n\n\n\n Bristol Myers Squibb \n\n\n\nIn looking beyond race and ethnicity\, Bristol Myers Squibb (BMS) is partnering with its Employee Resource Groups to explore diversity in clinical trials as it impacts other groups. Sharon Hanlon\, Head of Clinical Trials Engagement and Enrollment\, will discuss two recent BMS initiatives: “SOGIIS Data Collection Patients” which gives Patients the option to report demographic information relevant to their sexual orientation and gender identity and a “Clinical Trials Implications Assessment for Disabled Patients” which journey maps the clinical trial experience for disabled Patients\, identifying opportunities for growth. \n\n\n\n\n\n\n\n\n\n Novartis & U.S. Novartis Foundation \n\n\n\nNovartis and the U.S. Novartis Foundation have taken a major step forward in addressing the root causes of disparities in health and education with Beacon of Hope – a 10-year commitment to co-creating programs that address health and education inequities and create greater diversity\, equity\, inclusion and trust across the research and development ecosystem. Dr. Linda Armstrong\, Head of U.S. Corporate Responsibility and President of U.S. Novartis Foundation\, will provide an overview of this first-of-its-kind innovative collaboration with 26 Historically Black Colleges and Universities\, Merck\, Sanofi\, Amgen\, Alnylam\, the Global Black Economic Forum\, the National Medical Association\, Thurgood Marshall College Fund\, Coursera\, Advarra\, Virb and BeeKeeperAI. \n\n\n\n\n\n\n\n\n\n Janssen Pharmaceuticals \n\n\n\nJanssen’s “Research Includes Me” initiative seeks to identify needs\, build trust and break down barriers to access with a focus on traditionally underrepresented communities by providing educational materials\, addressing misperceptions\, hosting community events and connecting Patients to clinical research opportunities. Staci Hargraves\, Vice President of Portfolio Delivery Operations\, Global Development\, will share how Janssen partnered with industry groups\, such as the Society of Clinical Research Sites Diversity Awareness Program and Transcelerate’s Diversity in Clinical Trials workstream\, to develop programs and tools that foster better Patient experiences and care. \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and to ensure that “No Patient is ever left behind”.
URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar/
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230927T090000
DTEND;TZID=America/New_York:20230927T100000
DTSTAMP:20260504T221312
CREATED:20230901T120503Z
LAST-MODIFIED:20230925T162839Z
UID:8711-1695805200-1695808800@bionj.org
SUMMARY:Webinar: The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem
DESCRIPTION:The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem\n\n\n\nWednesday\, September 27\, 2023 ● 9:00 a.m.-10:00 a.m.\n\n\n\n\nRegister Today\n\n\n\n\nThe speed of innovation and acceleration in healthcare is nothing like we have ever seen before. The industry was picking up speed prior to the COVID-19 pandemic and since then we have seen an acceleration in everything from telemedicine\, to decentralized clinical trials\, to AI applied to everything from drug discovery to commercialization. That leaves us both with an amazing opportunity to solve some of the greatest healthcare challenges but also brings new complexities and issues we need to tackle from a privacy\, security\, legal and ethical standpoint. It will take everyone to both realize the potential and ensure we move forward in a measured and responsible way that does not hold back the very innovation that will save lives – why we all do what we do every day! \n\n\n\nJoin BioNJ and industry leaders on September 27 to dive into these topics with a focus on how we can all start to apply new technologies even in the smallest ways to make progress forward in what will prove to be one of the most dynamic eras of healthcare ahead.  \n\n\n\n\n\n\n\n\n Reed Abrahamson\, Partner\, Faegre Drinker \n\n\n\nAs a member of Faegre Drinker’s FDA Regulatory Team\, Reed advises clients in the life sciences industry\, including major pharmaceutical\, biotechnology and medical device companies\, on a wide range of issues associated with clinical trials and research. He assists in the development and negotiation of clinical trial agreements\, informed consent forms and other important research documents. Additionally\, Reed supports companies as they contract with research vendors and collaboration partners\, as well as helps companies implement privacy and security measures to support clinical trials and medical research. \n\n\n\n\n\n\n\n\n\n Lynne Anderson\, Partner\, Faegre Drinker \n\n\n\nLynne has a long history of working with life sciences/pharmaceutical clients. She is an experienced jury and bench trial lawyer with a track record of success in whistleblower/retaliation cases\, discrimination claims\, wage and hour class/collective actions and restrictive covenant disputes. Lynne’s litigation background provides the insight to effectively counsel clients who are dealing with strategic planning and frontline employee issues. She is Co-Chair of the BioNJ’s HR Committee and founding member and Co-Chair of BioNJ’s Inspiring Women of STEM Committee. \n\n\n\n\n\n\n\n\n\n Romain Bogaerts\, Director\, AI Product Management\, Real Chemistry \n\n\n\nRomain’s team builds both internal facing AI solutions and external AI products for life sciences companies. Internally\, the team has developed a Generative AI platform and other AI algorithms that empower the agency side of Real Chemistry to become exponentially more insightful. For clients\, Romain leads the design and development of innovative products: AdTech capabilities for Swoop to target the right Patient and HCP audiences\, HealthTech products at ipm.ai to identify undiagnosed Patients in specialty and MarTech data products that link SDOH and social media data to measure the impact of campaigns.  \n\n\n\n\n\n\n\n\n\n Jennifer Gottlieb\, Global President\, Chief Client Officer\, Real Chemistry \n\n\n\nJennifer is the Global President\, Chief Client Officer and member of the Board of Directors of Real Chemistry\, the leading provider of AI-driven insights and human-centric experiences for the healthcare industry. A healthcare pioneer — Jennifer’s career has been dedicated to driving strategic communications and commercial initiatives for clients in the pharmaceutical and biotechnology sectors as they navigate the ever-changing industry landscape. Jennifer takes on bold challenges\, including realizing the company’s vision to use AI and Ideas to transform the healthcare experience from what it is to what it should be. \n\n\n\n\nWe hope to see you on September 27 for this FREE educational webinar!
URL:https://bionj.org/event/webinar-the-technology-revolution-in-healthcare-is-in-sight-realizing-an-ai-driven-compliant-equitable-connected-healthcare-ecosystem/
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/09/Webinar-Banner-Faegre.png
END:VEVENT
END:VCALENDAR